Archives

by in
Entry Author Date Location
Cempra Milestone Highlights Experimental Antibiotic’s Potential 09/09/14 Raleigh Durham
7 Takeaways From “What’s Hot in Boston Biotech” 04/22/14 Boston
Layoffs Hit Optimer Following Cubist Buyout 12/06/13 New York
Flagship Takes a Stab at Microbiome Therapy With Seres Health 11/21/13 Boston
East Coast Life Sciences Roundup: Aileron, Enzymatics, Acton, & More 09/06/13 Boston
East Coast Biotech Roundup: Cubist, Acetylon, Foundation, & More 08/02/13 Boston
San Diego Life Sciences News: Trius, Optimer, aTyr, Ligand, and More 08/01/13 San Diego
Cubist Adds Antibiotic Punch, Buys Trius and Optimer for $1.24B 07/30/13 Boston
San Diego Life Sciences Roundup: Optimer, Ambit, AnaptysBio, & More 05/17/13 San Diego
East Coast Life Sciences Roundup: Optimer, Bind, Pfizer, and More 04/05/13 Boston
San Diego Life Sciences Roundup: Qualcomm, Amylin, Organovo & More 04/04/13 San Diego
Optimer Shares Soar Amid Reports of Buyout Interest 04/02/13 San Diego
East Coast Life Sciences Roundup: Third Rock, SciFluor, Cubist 03/01/13 Boston
San Diego Life Sciences Roundup: Optimer, Zogenix, MediciNova, & More 03/01/13 San Diego
Optimer Board Ousts CEO, Brings Back Former Pfizer CEO McKinnell 02/27/13 San Diego
San Diego Life Sciences Roundup: Optimer, Volcano, Avelas Bio, & More 12/07/12 San Diego
San Diego Life Sciences Roundup: Optimer, Pfenex, OncoSec, & More 10/19/12 San Diego
San Diego Life Sciences Roundup: Optimer, CareFusion, Senomyx & More 10/11/12 San Diego
SD Life Sciences Roundup: Optimer, Illumina, & Deals, Deals, Deals 04/12/12 San Diego
Optimer Discloses Shakeup Prompted by Chairman’s Deal in Taiwan 04/09/12 National
San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy 02/03/12 San Diego
AvidBiotics Sees New Angle for Personalized Medicine in Antibiotics 02/01/12 San Francisco
Optimer, Following Pfizer’s Playbook, Has Big Plans for Antibiotic 01/31/12 San Diego
San Diego Life Sciences Roundup: BeneChill, Sotera, Imthera, & More 12/16/11 San Diego
Optimer Wins EU Approval for New Antibiotic 12/12/11 San Diego
Groupon: The IPO With More Sizzle, and Money, Than the Entire Biotech IPO Class of 2011 11/07/11 National
Optimer Pulls in $10.6M in Sales, With Commercial Rollout of New Antibiotic 11/03/11 San Diego
Elevation Partners Grabs $17M, NanoSort Wins Grants, NIH Collaborates with Afraxis on Rare Disease R&D, & More San Diego Life Sciences News 09/29/11 San Diego
Biotech is Biggest Winner in Second-Quarter VC Funding, Zogenix Strategy Unfolds, Intellikine Builds Clinical Trial Capabilities, & More San Diego Life Sciences News 07/21/11 San Diego
FDA Approves Optimer Antibiotic, Amylin Wins Legal Round Against Lilly, Investors Excited by Orexigen Move, & More San Diego Life Sciences News 06/02/11 San Diego
Page 1 of 3 next page »